Ose Immunotherapeutics Sa has released a press release.
Informations relatives au nombre total de droits de vote et d’actions composant le capital
Earlier from Ose Immunotherapeutics Sa
- OSE Immunotherapeutics Reports Results of its 2026 Annual General Meeting
- Annual General Meeting on June 24, 2026 Procedures for obtaining preparatory documents for the General Meeting
- OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document